Eric D Weinhandl

Summary

Affiliation: Chronic Disease Research Group
Country: USA

Publications

  1. doi request reprint Hemoglobin variability and mortality: confounding by disease severity
    Eric D Weinhandl
    Minneapolis Medical Research Foundation, MN, USA
    Am J Kidney Dis 57:255-65. 2011
  2. pmc Hemoglobin level variability: associations with mortality
    David T Gilbertson
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, Suite S 206, Minneapolis, MN 55404, USA
    Clin J Am Soc Nephrol 3:133-8. 2008
  3. doi request reprint Clinical outcomes associated with receipt of integrated pharmacy services by hemodialysis patients: a quality improvement report
    Eric D Weinhandl
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Am J Kidney Dis 62:557-67. 2013
  4. pmc Survival in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients
    Eric D Weinhandl
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, MN 55404, USA
    J Am Soc Nephrol 23:895-904. 2012
  5. doi request reprint Association of mean weekly epoetin alfa dose with mortality risk in a retrospective cohort study of Medicare hemodialysis patients
    Eric D Weinhandl
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, Minneapolis, MN 55404, USA
    Am J Nephrol 34:298-308. 2011
  6. ncbi request reprint Protective effect of intravenous levocarnitine on subsequent-month hospitalization among prevalent hemodialysis patients, 1998 to 2003
    Eric D Weinhandl
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Am J Kidney Dis 50:803-12. 2007
  7. pmc Comparative mortality of hemodialysis patients at for-profit and not-for-profit dialysis facilities in the United States, 1998 to 2003: a retrospective analysis
    Robert N Foley
    United States Renal Data System, 914 South 8th Street, Suite S 406, Minneapolis, Minnesota, USA
    BMC Nephrol 9:6. 2008
  8. ncbi request reprint Association between number of months below K/DOQI haemoglobin target and risk of hospitalization and death
    Areef Ishani
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, Suite S 253, Minneapolis, MN 55404, USA
    Nephrol Dial Transplant 23:1682-9. 2008
  9. ncbi request reprint Linking Centers for Medicare & Medicaid Services data with prospective DCOR trial data: methods and data comparison results
    Wendy L St Peter
    The College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA
    Hemodial Int 12:480-91. 2008
  10. pmc Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients
    Eric D Weinhandl
    Chronic Disease Research Group, Minneapolis, MN 55404, USA
    J Am Soc Nephrol 21:499-506. 2010

Detail Information

Publications16

  1. doi request reprint Hemoglobin variability and mortality: confounding by disease severity
    Eric D Weinhandl
    Minneapolis Medical Research Foundation, MN, USA
    Am J Kidney Dis 57:255-65. 2011
    ..Adequate adjustment for confounding by disease severity is needed to estimate the association of hemoglobin level variability with mortality risk...
  2. pmc Hemoglobin level variability: associations with mortality
    David T Gilbertson
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, Suite S 206, Minneapolis, MN 55404, USA
    Clin J Am Soc Nephrol 3:133-8. 2008
    ..4%; intermediate-intermediate (I-I), 6.0%; high-high (H-H), 2.3%; low-intermediate (L-I), 18.3%; intermediate-high (I-H), 31.7%, and low-high (L-H), 40.2%...
  3. doi request reprint Clinical outcomes associated with receipt of integrated pharmacy services by hemodialysis patients: a quality improvement report
    Eric D Weinhandl
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Am J Kidney Dis 62:557-67. 2013
    ..In 2005, a large US dialysis organization created an integrated pharmacy program for its patients. We aimed to compare the outcomes of hemodialysis patients enrolled in this program and matched control patients...
  4. pmc Survival in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients
    Eric D Weinhandl
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, MN 55404, USA
    J Am Soc Nephrol 23:895-904. 2012
    ..Continued surveillance should strengthen inference about causes of mortality and determine whether treatment effects are homogeneous throughout the dialysis population...
  5. doi request reprint Association of mean weekly epoetin alfa dose with mortality risk in a retrospective cohort study of Medicare hemodialysis patients
    Eric D Weinhandl
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, Minneapolis, MN 55404, USA
    Am J Nephrol 34:298-308. 2011
    ..Appropriately designed observational studies are needed to clarify the association of ESA dosing with mortality risk...
  6. ncbi request reprint Protective effect of intravenous levocarnitine on subsequent-month hospitalization among prevalent hemodialysis patients, 1998 to 2003
    Eric D Weinhandl
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Am J Kidney Dis 50:803-12. 2007
    ..Levocarnitine deficiency in hemodialysis patients is common. Although the effect of intravenous levocarnitine therapy was studied in small trials, the effect on global outcomes in larger populations is unclear...
  7. pmc Comparative mortality of hemodialysis patients at for-profit and not-for-profit dialysis facilities in the United States, 1998 to 2003: a retrospective analysis
    Robert N Foley
    United States Renal Data System, 914 South 8th Street, Suite S 406, Minneapolis, Minnesota, USA
    BMC Nephrol 9:6. 2008
    ....
  8. ncbi request reprint Association between number of months below K/DOQI haemoglobin target and risk of hospitalization and death
    Areef Ishani
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, Suite S 253, Minneapolis, MN 55404, USA
    Nephrol Dial Transplant 23:1682-9. 2008
    ..We aimed to determine the consequences associated with cumulative number of months below target haemoglobin concentrations...
  9. ncbi request reprint Linking Centers for Medicare & Medicaid Services data with prospective DCOR trial data: methods and data comparison results
    Wendy L St Peter
    The College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA
    Hemodial Int 12:480-91. 2008
    ..Linking patients to the data-rich CMS ESRD database allowed assessment of additional important secondary end points at a relatively low cost compared with prospective data collection...
  10. pmc Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients
    Eric D Weinhandl
    Chronic Disease Research Group, Minneapolis, MN 55404, USA
    J Am Soc Nephrol 21:499-506. 2010
    ..These data suggest that increased use of peritoneal dialysis may benefit incident ESRD patients...
  11. doi request reprint A simple tool to predict outcomes after kidney transplant
    Bertram L Kasiske
    Department of Medicine, Hennepin County Medical Center, University of Minnesota, Minneapolis, MN 55415, USA
    Am J Kidney Dis 56:947-60. 2010
    ..Surprisingly few tools have been developed to predict outcomes after kidney transplant...
  12. ncbi request reprint Anaemia and mortality in haemodialysis patients: interaction of propensity score for predicted anaemia and actual haemoglobin levels
    Tricia L Roberts
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, MN 55404, USA
    Nephrol Dial Transplant 21:1652-62. 2006
    ..Thus, integrating factors predictive of anaemia with actual haemoglobin levels might improve prognostic discrimination...
  13. doi request reprint Issues regarding 'immortal time' in the analysis of the treatment effects in observational studies
    Jiannong Liu
    United States Renal Data System, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Kidney Int 81:341-50. 2012
    ..Results from the DaVita data were consistent with the simulation. Careful consideration of methodology is needed in observational analyses with time-dependent treatment...
  14. ncbi request reprint Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators
    Charles A Herzog
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Kidney Int 68:818-25. 2005
    ..The objective of this retrospective cohort study was to determine ICD use in dialysis patients and impact on survival...
  15. pmc Estimated number of prevalent cases of metastatic bone disease in the US adult population
    Shuling Li
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN, USA
    Clin Epidemiol 4:87-93. 2012
    ..The prevalence of metastatic bone disease in the US population is not well understood. We sought to estimate the current number of US adults with metastatic bone disease using two large administrative data sets...
  16. pmc Comparative effectiveness of calcium acetate and sevelamer on clinical outcomes in elderly hemodialysis patients enrolled in medicare part d
    Akeem A Yusuf
    US Renal Data System, Minneapolis Medical Research Foundation, Minneapolis, MN University of Minnesota, College of Pharmacy, Minneapolis, MN
    Am J Kidney Dis 64:95-103. 2014
    ..Phosphate binders are an important therapeutic option for managing hyperphosphatemia in hemodialysis patients. Whether sevelamer confers a survival advantage over calcium acetate is unclear...